Vertex Pharmaceuticals held its Q2 2024 earnings call, discussing financial results and future outlook. Executives highlighted strong performance, potential launches, and promising developments in various therapeutic areas.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing